Talledo, Nenita F.
HRN: 08-53-62 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/01/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
07/01/2023
07/22/2023
IV
4.5 Grams
Q6H
Infected Wound; T/C Necrotizing Fasciitis
Waiting Final Action
Indication: EmpiricEmpirical De-escalation Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes